Oral Azacitidine Matches Injection Exposure in MDS Study
Taiho reported detailed AZTOUND data on November 4 after a September topline announcement. In 83 patients in a randomized crossover Phase 3 pharmacokinetic analysis, oral azacitidine plus cedazuridine produced a total-cycle exposure ratio of…
